{"count": 2, "results": [{"_id": "34776938", "pmid": 34776938, "pmcid": "PMC8589019", "title": "Long-Term Use of Metformin Is Associated With Reduced Risk of Cognitive Impairment With Alleviation of Cerebral Small Vessel Disease Burden in Patients With Type 2 Diabetes", "journal": "Front Aging Neurosci", "authors": ["Teng Z", "Feng J", "Qi Q", "Dong Y", "Xiao Y", "Xie X", "Meng N", "Chen H", "Zhang W", "Lv P"], "date": "2021-10-29T00:00:00Z", "doi": "10.3389/fnagi.2021.773797", "meta_date_publication": "2021", "meta_volume": "13", "meta_issue": "", "meta_pages": "773797", "score": 50298.855, "text_hl": "To the best of our knowledge, few studies have investigated the relationship between @<m>DISEASE_Cerebral_Small_Vessel_Diseases</m> @DISEASE_MESH:D059345 @@@CSVD@@@ burden and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ use, although @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ could act on some of the mechanisms that lead to @<m>DISEASE_Cerebral_Small_Vessel_Diseases</m> @DISEASE_MESH:D059345 @@@CSVD@@@. ", "citations": {"NLM": "Teng Z, Feng J, Qi Q, Dong Y, Xiao Y, Xie X, Meng N, Chen H, Zhang W, Lv P. Long-Term Use of Metformin Is Associated With Reduced Risk of Cognitive Impairment With Alleviation of Cerebral Small Vessel Disease Burden in Patients With Type 2 Diabetes Front Aging Neurosci. 2021;13():773797. PMID: 34776938", "BibTeX": "@article{34776938, title={Long-Term Use of Metformin Is Associated With Reduced Risk of Cognitive Impairment With Alleviation of Cerebral Small Vessel Disease Burden in Patients With Type 2 Diabetes}, author={Teng Z and Feng J and Qi Q and Dong Y and Xiao Y and Xie X and Meng N and Chen H and Zhang W and Lv P}, journal={Front Aging Neurosci}, volume={13}, pages={773797}}"}}, {"_id": "38043334", "pmid": 38043334, "title": "Neuroprotective effects of oral metformin before stroke on cerebral small-vessel disease.", "journal": "J Neurol Sci", "authors": ["Akiyama N", "Yamashiro T", "Ninomiya I", "Uemura M", "Hattori Y", "Ihara M", "Onodera O", "Kanazawa M"], "date": "2023-11-30T00:00:00Z", "doi": "10.1016/j.jns.2023.122812", "meta_date_publication": "2023 Nov 30", "meta_volume": "456", "meta_issue": "", "meta_pages": "122812", "score": 50271.645, "text_hl": "Neuroprotective effects of oral @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ before @DISEASE_Stroke @DISEASE_MESH:D020521 @@@stroke@@@ on @<m>DISEASE_Cerebral_Small_Vessel_Diseases</m> @DISEASE_MESH:D059345 @@@cerebral small-vessel disease@@@.", "citations": {"NLM": "Akiyama N, Yamashiro T, Ninomiya I, Uemura M, Hattori Y, Ihara M, Onodera O, Kanazawa M. Neuroprotective effects of oral metformin before stroke on cerebral small-vessel disease. J Neurol Sci. 2023 Nov 30;456():122812. PMID: 38043334", "BibTeX": "@article{38043334, title={Neuroprotective effects of oral metformin before stroke on cerebral small-vessel disease.}, author={Akiyama N and Yamashiro T and Ninomiya I and Uemura M and Hattori Y and Ihara M and Onodera O and Kanazawa M}, journal={J Neurol Sci}, volume={456}, pages={122812}}"}}]}